Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...

Efficient RNA interference in Caenorhabditis elegans requires a distinct class of secondary short interfering RNA. Although many proteins involved in RNAi were initially studied in the context of ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

The decision to expand the development plan follows recently reported promising preclinical findings demonstrating that ...

Plants and fungi can use conserved RNA interference machinery to regulate each other’s gene expression—and scientists think they can make use of this phenomenon to create a new generation of ...

In 1998, Andrew Fire and Craig Mello published a groundbreaking study demonstrating that double-stranded RNA (dsRNA) could silence genes in the nematode Caenorhabditis elegans. This discovery laid the ...

RNAi – functions specifically to silence, or deactivate, genes. Among other applications, it promises to be groundbreaking as ...

Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.

The study demonstrates that this RNAi approach shuts down vital fungal genes, thereby inhibiting pathogen growth - a ...

The aggregate gross proceeds to Benitec from the underwritten offering and the concurrent registered direct offering are expected to be approximately $30 million, prior to deducting underwriting ...